Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Middle East respiratory syndrome coronavirus (MERS-CoV) poses a significant public health threat.
• Understanding the human immune response to MERS-CoV is vital for effective disease control and therapeutic strategies.
• Immune memory and antibody persistence following MERS-CoV infection are not fully characterized.

Purpose of the Study:

• To investigate the long-term antibody responses in individuals who survived MERS-CoV infection.
• To determine the duration of MERS-CoV-specific neutralizing antibodies in recovered patients.
• To inform the development of vaccines and treatments for MERS-CoV.

Main Methods:

• Study included 48 human MERS-CoV infection survivors from Saudi Arabia with varying disease severity.
• Analysis of MERS-CoV-specific antibody levels and neutralizing capacity over time post-infection.

Main Results:

• MERS-CoV-specific neutralizing antibodies were detected in all studied survivors.
• Antibody persistence was observed for up to 6 years following the initial MERS-CoV infection.
• The duration of antibody response suggests long-term immunological memory.

Conclusions:

• Individuals surviving MERS-CoV infection develop durable neutralizing antibody responses.
• The findings support the potential for long-lasting immunity after MERS-CoV infection.
• This long-term antibody presence is a critical factor for MERS-CoV vaccine design and efficacy evaluation.